Monday 19th May 2025 13:00 - 14:00 (BST)
As China’s healthcare market undergoes significant transformation, global market access professionals must stay ahead of its evolving landscape.
Understanding the National Reimbursement Drug List (NRDL) process, evaluation methods, and recent reforms is essential for navigating the opportunities and challenges presented by the world’s second-largest pharmaceutical market.
In this 60-minute masterclass, a panel of local market experts – Bruce Crawford, Patrick Hopkinson and Anthony Morton-Small – will provide insights into China’s unique healthcare dynamics.
This session will also examine how China’s reimbursement systems compare to global frameworks, such as NICE, and what the future holds for balancing innovation, access, and affordability.

19th May 2025 13:00 – 14:00 (BST)
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now